Related Experiment Video
Updated: Sep 7, 2025

03:37
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
885
Inferring disease progression and gene regulatory networks from clinical transcriptomic data using PROB_R
1School of Mathematics, Sun Yat-sen University, Guangzhou 510275, China.
STAR Protocols
|June 23, 2022
Summary
This study introduces PROB_R, a method to infer gene regulatory networks and disease progression from static transcriptomic data. It reconstructs gene expression dynamics and identifies key regulators, aiding in understanding complex diseases.
Area of Science:
- Bioinformatics
- Computational Biology
- Genomics
Background:
- Inferring gene regulatory networks (GRNs) from clinical transcriptomic data is challenging due to the lack of explicit temporal information.
- Cross-sectional studies provide snapshots but miss dynamic biological processes and disease progression.
- Understanding temporal dynamics is crucial for deciphering complex diseases and identifying therapeutic targets.
Purpose of the Study:
- To present the PROB_R protocol for inferring latent temporal disease progression.
- To reconstruct gene regulatory networks from cross-sectional transcriptomic data.
- To identify key regulatory genes involved in disease progression.
Main Methods:
- The PROB_R protocol utilizes cross-sectional transcriptomic data to infer pseudo-temporal disease progression.
- It applies network inference algorithms to reconstruct gene regulatory networks.
- The method was validated on a breast cancer dataset.
Main Results:
- PROB_R successfully recovered pseudo-temporal gene expression dynamics aligned with disease progression.
- The protocol reconstructed gene regulatory networks from static data.
- Key regulatory genes driving disease progression were identified.
Conclusions:
- PROB_R offers a robust method for inferring temporal dynamics and GRNs from cross-sectional transcriptomic data.
- This approach enhances our understanding of disease progression and gene regulation.
- The identified key regulators can serve as potential therapeutic targets.

